Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure
Authors:
- Uri ElkayamUEUri Elkayam
- Arie RothARArie Roth
- Willa HsuehWHWilla Hsueh
- Laura WeberLWLaura Weber
- Lindalee FreidenbergerLFLindalee Freidenberger
- Shahbudin H. RahimtoolaSRShahbudin H. Rahimtoola
- 1 June 1986
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 111 (6) , 1130-1138
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- The Neurohumoral Axis in Congestive Heart FailureAnnals of Internal Medicine, 1984
- Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failureThe American Journal of Cardiology, 1983
- Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticismJACC, 1983
- Central and regional hemodynamic effects and neurohumoral consequences of minoxidil in severe congestive heart failure and comparison to hydralazine and nitroprussideThe American Journal of Cardiology, 1983
- The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: Response to specific inhibitors (prazosin and captopril)The American Journal of Cardiology, 1982
- Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failureClinical Pharmacology & Therapeutics, 1981
- Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failureThe American Journal of Medicine, 1981
- Rebound Hemodynamic Events after the Abrupt Withdrawal of Nitroprusside in Patients with Severe Chronic Heart FailureNew England Journal of Medicine, 1979
- Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failureThe American Journal of Cardiology, 1979